Innovate and Stretch Your Footprint in the Community: Telepharmacy

Total Page:16

File Type:pdf, Size:1020Kb

Innovate and Stretch Your Footprint in the Community: Telepharmacy 6/29/2018 #FSHP2018 Disclosure Innovate and stretch your • I have no conflicts of interest related to this presentation footprint in the community: Telepharmacy Leah Loeffler Pharm D, BCPS Clinical Hospital Pharmacist: Transitions of Care Jackson Memorial Hospital #FSHP2018 Objectives • Define the definition of telehealth and telepharmacy Who is currently using telehealth in their • List the barriers and benefits of telepharmacy practice today? • Identify opportunities for expansion of the pharmacist role through telepharmacy • Describe the integration of telepharmacy into pharmacy practice • Review Federal and State pharmacy profession regulations regarding telepharmacy #FSHP2018 #FSHP2018 Introduction to Telehealth1,2 Key Terms1 • As many as 75 million telehealth encounters are expected in North America annually 1. Telemonitoring • Health Resources and Services Administration (HRSA) has projected a need for 3,060 additional primary care physicians (PCPs) in Florida 2. Store-and-forward (asynchronous) by 2025 3. Video conferencing (synchronous) • The vast majority of the United States population has a cellphone, 4. Distance (hub) site including 92% of adults with an income of < $30,000 a year • Over 97% of Floridians have access to wireline services and 100% have access 5. Originating site to high-speed mobile service 6. Interoperability • Telehealth is a reimbursable service in Medicaid programs in all but two states Connecticut Rhode Island #FSHP2018 #FSHP2018 1 6/29/2018 Technology Timeline3 What is Telehealth?1 1876 1928 • Definition: Alexander Television is 1972 1991 Graham Bell introduced in Ray World Wide invents the the United Tomlinson Web Opens Telehealth is the use of electronic information and "telephone“ States Invents Email to Public telecommunication technologies to provide long-distance health care and education to patients • What: Eligible technologies include: videoconferencing, store-and- 1879 1958 1974 1996 forward, remote patient monitoring, and telephone calls Thomas Bell Labs Vint Cerf, Email Edison Invents Robert Kahn Surpasses demonstrates Modem Coin Postal Mail • Why: the carbon 'Internet‘ filament light Telehealth strategies are used to provide patient care services bulb and optimize outcomes #FSHP2018 #FSHP2018 What is telepharmacy?4 telepharmacy Services4 • Drug review and monitoring “The provision of pharmacist care by registered pharmacies and pharmacists located within U.S. jurisdictions through the • Dispensing use of telecommunications or other technologies to patients • Sterile and nonsterile compounding verification or their agents at distances that are located within U.S. • Medication therapy management (MTM) jurisdictions.” • Patient assessment • Patient counseling -Model State Pharmacy Act and Model Rules of the National Association of Boards of Pharmacy • Clinical consultation • Outcomes assessment • Drug information #FSHP2018 #FSHP2018 Patient : Barriers to Barriers to telepharmacy Patient telepharmacy1 Patient • Motivation to adhere to monitoring and telehealth visits • Ability to maintain and operate devices • Telephone and Internet access preferred • Insurance coverage or other means for Clinical Tele- reimbursement Pharma- health cist Team #FSHP2018 #FSHP2018 2 6/29/2018 Telehealth Team: Barriers to Telehealth Clinical Pharmacist: Barriers to Clinical telepharmacy1,5 Team telepharmacy1,5 Pharmacist • Infrastructure to support telehealth services • Knowledge of the availability, features, and limitations of • Knowledge of the features and limitations of remote remote monitoring devices monitoring devices • An electronic health record (EHR) to transfer data and care • Ability to access monitoring data, manage alerts, and responsibilities among team members input plans into the EHR • Data sharing and trust agreements in place • Adherence to HIPAA regulations to ensure confidentiality of patient information • Adherence to HIPAA regulations to ensure confidentiality of patient information • Data sharing and trust agreements in place • Government restrictions on the use of telehealth in managed • Cost of equipment care #FSHP2018 #FSHP2018 1 Integration of telepharmacy Benefits of telepharmacy into Pharmacy Practice6 HCP Time Decrease HCP Hospitaliza Resources Retail Ambulatory Inpatient -tions Reduce Assist in Transporta ToC -tion Cost #FSHP2018 Opportunities in telepharmacy Integration of telepharmacy Programs1 into Pharmacy Practice1 • Anticoagulation • Comprehensive Medication Management • Diabetes • Medication Therapy Management • Hepatitis C • Transitions of Care • Hypertension • Physician-pharmacist collaborative practice #FSHP2018 #FSHP2018 3 6/29/2018 Comprehensive Medication Comprehensive Medication Management1 Management1 Qualifications for practice do not change 1. Assessing the patient and evaluating medication therapy •Maintaining patient safety and privacy 2. Technology requirements for assessing the patient and Private and secure area evaluating medication therapy Patient must be made aware of technologists or assistants 3. Developing and implementing a plan of care Lighting and camera placement 4. Technology requirements for developing and implementing a •Protecting the patient–pharmacist relationship plan of care •Enhancing communication and coordination of care 5. Follow-up Evaluation and Medication Monitoring EHR and Health information exchange (HIE) 6. Technology requirements for follow-up evaluation Secure e-mail, facsimile, instant messaging or text message 7. Documentation #FSHP2018 #FSHP2018 Medication Therapy 8 Management (MTM)7 Transitions of Care 1. An Interactive Contact (within 24-48 hours) MTM must be documented in consistently for • Telephone patients and billing purposes • Email • Face-to-face 1. Annual comprehensive medication review (CMR) 2. Certain Non-face-to-face Services • Provide education to the patient/caretaker to support self- • Interactive person-to-person visit management, independent living, and activities of daily living • Telehealth consultation • Assess and support treatment regimen adherence and medication 2. Quarterly targeted medication reviews (TMRs) management • Person-to-person (by phone) is acceptable • Identify available community and health resources • Assist the patient and/or family in accessing needed care and services #FSHP2018 #FSHP2018 Transitions of Care8 3. A face-to-face Visit • As of January 1, 2014; you may use CPT codes 99495 and 99496 for a telehealth service Objective To assess the effect of a telephone-based care-management strategy on medical costs and resource utilization Primary Outcome Cost of care and the use of hospital, emergency room, and outpatient services, as well as selected surgical procedures Intervention The enhanced-support group received up to five outreach attempts versus three in the usual-support group • Supplemented with web links, video and print materials Results - Monthly pharmacy costs per person ($213.82 vs. $221.78, P = 0.05)10.1% - Reduction in annual hospital admissions (P<0.001) #FSHP2018 #FSHP2018 4 6/29/2018 Technology Infrastructure Objective To evaluate an online disease management system supporting patients with uncontrolled type 2 diabetes Primary Outcome A1C was the primary outcome variable Intervention (1) wirelessly uploaded home glucometer readings with graphical feedback (2) comprehensive patient-specific diabetes summary status report (3) nutrition and exercise logs (4) insulin record (5) online messaging with the patient’s health team (6) nurse care manager and dietitian providing advice and medication management (7) personalized text and educational videos dispensed electronically by the care team Results - A1C at 6 months (−1.32% INT vs −0.66% UC; p<0.001) - A1C at 12 months (−1.14% INT vs −0.95% UC; p=0.133) #FSHP2018 #FSHP2018 Telehealth Services1,2 Costs and Compensation1,5 • Programs between health plan payers and • Reimbursable telehealth services medical/pharmacy services Consultations Kaiser Permanente Office visits Cigna Pharmacologic management Aetna • Asynchronous “store-and-forward visits” are not covered if • Systems that document interactions there is no direct patient contact Teladoc • Medicaid less restrictive compared to Medicare McKesson’s RelayHealth State and site of service • Data exchange systems Technology used eHealthExchange Distance between the patient’s home and provider’s location Carequality #FSHP2018 #FSHP2018 Federal Regulation2,4,5 State Regulation2,4,5,12 • Centers for Medicare and Medicaid Services (CMS) Standards Florida composite grade for telehealth is a B for telepharmacy Medicare has strict requirements: geographic location, care setting, • Florida Medicaid fee-for-service updated to a broader array and specific technological modalities of licensed health care practitioners and settings Medicare Telehealth Parity Act • All health care practitioners providing care to Florida • Medicare Prescription Drug, Improvement, and Modernization residents using telehealth have to be licensed in Florida Act of 2003 • Mental/behavioral health and medication management are • Health Information Technology for Economic and Clinical the most covered services via telemedicine Health (HITECH) Act and the Health Information Exchange • The Agency provides governance for the statewide Heath (HIE) Information Exchange (HIE) program • FDA Standards #FSHP2018 #FSHP2018 5 6/29/2018 American Telemedicine Association (ATA)5,12 • The voice and primary authority about telehealth that actively works with Congress • State Telemedicine
Recommended publications
  • World Journal of Advanced Research and Reviews
    World Journal of Advanced Research and Reviews, 2020, 07(02), 218–226 World Journal of Advanced Research and Reviews e-ISSN: 2581-9615, Cross Ref DOI: 10.30574/wjarr Journal homepage: https://www.wjarr.com (RESEARCH ARTICLE) Implementation and evaluation of telepharmacy during COVID-19 pandemic in an academic medical city in the Kingdom of Saudi Arabia: paving the way for telepharmacy Abdulsalam Ali Asseri *, Mohab Mohamed Manna, Iqbal Mohamed Yasin, Mashael Mohamed Moustafa, Fatmah Mousa Roubie, Salma Moustafa El-Anssasy, Samer Khalaf Baqawie and Mohamed Ahmed Alsaeed Associate Professor Imam Abdulrahman Bin Faisal University; Director of Pharmacy services at King Fahad University Hospital, KSA. Publication history: Received on 07 July 2020; revised on 22 August 2020; accepted on 25 August 2020 Article DOI: https://doi.org/10.30574/wjarr.2020.7.2.0250 Abstract King Fahad University Hospital, a leading public healthcare institution in the Eastern region of KSA, implemented a disruptive innovation of Telepharmacy in pursuit of compliance with the National COVID-19 Response Framework. It emerged and proved to be an essential and critical pillar in suppression and mitigation strategies. Telepharmacy innovation resulted in Pharmacy staffing protection and provided uninterrupted access and care continuum to the pharmaceutical services, both for COVID-19 and Collateral care. This reform-oriented initiative culminated in adopting engineering and administrative controls to design the workflows, practices, and interactions between healthcare providers, patients, and pharmaceutical frontline staff. Pharmaceutical services enhanced its surge capacity (14,618 OPD requests & 10,030 Inpatient orders) and improved capability (41,242 counseling sessions) to address the daunting challenge of complying with the inpatient needs and robust outpatient pharmaceutical consumer services.
    [Show full text]
  • Patient Care Through Telepharmacy September 2016
    Patient Care through Telepharmacy September 2016 Gregory Janes Objectives 1. Describe why telepharmacy started and how it has evolved with technology 2. Explain how telepharmacy is being used to provide better patient care, especially in rural areas 3. Understand the current regulatory environment around the US and what states are doing with regulation Agenda ● Origins of Telepharmacy ● Why now? ● Telepharmacy process ● Regulatory environment ● Future Applications Telepharmacy Prescription verification CounselingPrescription & verification Education History Origins of Telepharmacy 1942 Australia’s Royal Flying Doctor Service 2001 U.S. has first state pass telepharmacy regulation 2003 Canada begins first telepharmacy service 2010 Hong Kong sees first videoconferencing consulting services US Telepharmacy Timeline 2001 North Dakota first state to allow 2001 Community Health Association in Spokane, WA launches program 2002 NDSU study begins 2003 Alaska Native Medical Center program 2006 U.S. Navy begins telepharmacy 2012 New generation begins in Iowa Question #1 What was the first US state to allow Telepharmacy? a) Alaska b) North Dakota c) South Dakota d) Hawaii Question #1 What was the first US state to allow Telepharmacy? a) Alaska b) North Dakota c) South Dakota d) Hawaii NDSU Telepharmacy Study Study from 2002-2008 ● 81 pharmacies ○ 53 retail and 28 hospital ● Rate of dispensing errors <1% ○ Compared to national average of ~2% ● Positive outcomes, mechanisms could be improved Source: The North Dakota Experience: Achieving High-Performance
    [Show full text]
  • Pharmacotherapy-Enhancing Drugs
    EDITORIAL NOTE Pharmacotherapy-Enhancing drugs Robin Karli* Karli R. Pharmacotherapy-Enhanced drugs. Clin Pharmacol Toxicol Res. 2021;4(2):1. DESCRIPTION Pharmacotherapy is related to several diseases and disorders. The medication varies from one disease or disorder to the other. Pharmacotherapy is provided to diseases and disorders related to Cardiovascular, respiratory, n the treatment of addiction, medications are wanted to reduce the gastrointestinal, renal, neurological, psychiatric, endocrinologic, gynecologic I intensity of withdrawal symptoms, reduce alcohol and other drug craving and obstetric, urological, immunologic, rheumatologic, ophthalmic, and reduce the likelihood of use or relapse for specific drugs by blocking dermatologic, hematologic, infectious diseases, oncologic and nutritional their effect. The primary goal of medication-assisted treatment is for the disorders. patient to achieve fully-sustained remission. SELECTION OF AN ANTIDEPRESSANT MEDICATION Pharmacotherapy is therapy using pharmaceutical drugs, as distinguished from therapy using surgery (surgical therapy), radiation (radiation therapy), movement (physical therapy), or other modes. Among The overall effectiveness of antidepressant medications is usually equivalent between and within classes of medicines. However, there are distinct physicians, sometimes the term medical therapy refers specifically to differences in individual patient response to and side effects caused by the pharmacotherapy as against surgical or other therapy; as an example, in classes of medicines and individual agents. The genetic differences within the oncology, medical oncology is thus distinguished from surgical oncology. metabolism of certain medications including antidepressants are often Pharmacists are experts in pharmacotherapy and are liable for ensuring determined by cytochrome P450 genetic testing. This testing may identify the safe, appropriate, and economical use of pharmaceutical drugs.
    [Show full text]
  • Self-Management Strategies and Patient Education
    Self-Management Strategies and Patient Education • Cynthia Olivas, MSN • Nurse Manager: ECHO Pain & Rheumatology TeleECHO Clinics • March 9, 2015 I have nothing to disclose. Objectives 1. Describe Self-Management Strategies 2. Define the Five A’s Model 3. Describe how functional goals can contribute to patient engagement in their plan of care 4. Discuss Performance-Function and Life Improvement Plans 5. Identify how to utilize change plans to engage patients in self-management strategies Chronic Pain Experience • Chronic pain (or any chronic condition) is best understood as a process that evolves over time • The chronic pain experience results from the entire progression of the patient’s illness, the sociocultural context in which it occurs, and the interactions between healthcare professionals and patients Osterweis, M., Kleinman, A. Mechanic, D., Pain and Disability: clinical behavioral and public policy perspectives. Washington, DC: National Academy Press, 1987 Distinction between simple and complex pain Simple: Chronic pain responds to standard treatments • Patient is generally functional • Interactions are mutually satisfying Complex: Chronic pain does not respond to standard treatments (this includes education) • Syndrome across all painful conditions • Declining function over time in spite of progressively more aggressive, expensive, and risky medical treatments • History of complicated or mysterious presentations to multiple providers • Mutually unpleasant interactions (provider to patient – patient to provider – patient to loved ones or acquaintances) Why use the Chronic Care Model for pain care? This model can provide for productive interactions between patient, their families, and the care team. There are six elements to the care model that influence the ability to deliver effective chronic illness care: 1.
    [Show full text]
  • Supporting Self-Management in Patients with Chronic Illness MARY THOESEN COLEMAN, M.D., PH.D., and KAREN S
    Supporting Self-management in Patients with Chronic Illness MARY THOESEN COLEMAN, M.D., PH.D., and KAREN S. NEWTON, M.P.H. University of Louisville School of Medicine, Louisville, Kentucky Support of patient self-management is a key component of effective chronic illness care and improved patient outcomes. Self-management support goes beyond traditional knowledge-based patient education to include processes that develop patient problem-solving skills, improve self-efficacy, and support application of knowledge in real-life situa- tions that matter to patients. This approach also encompasses system- focused changes in the primary care environment. Family physicians can support patient self-management by structuring patient-physician interactions to identify problems from the patient perspective, making office environment changes that remove self-management barriers, and providing education individually and through available com- munity self-management resources. The emerging evidence supports the implementation of practice strategies that are conducive to patient self-management and improved patient outcomes among chronically ill patients. (Am Fam Physician 2005;72:1503-10. Copyright © 2005 American Academy of Family Physicians.) See editorial on global rise in life expectancy and interventions in individual nonmanaged page 1454. an increase in cultural and envi- care practices has yet to be determined.3,5-7 A ronmental risks such as smoking, review7 of 41 studies assessing interventions unhealthy diet, lack of physical to improve diabetes outcomes in primary A activity, and air pollution are associated with care revealed that adding patient-oriented an epidemic of chronic illness. Approxi- interventions can lead to improvements mately 120 million Americans have one or in outcomes such as glycemic control.
    [Show full text]
  • Enhancing Personal Health Record Adoption Through the Community Pharmacy Network: a Service Project Michael Veronin
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by INNOVATIONS in pharmacy (Iip - E-Journal) Volume 6 | Number 4 Article 221 2015 Enhancing Personal Health Record Adoption Through the Community Pharmacy Network: A Service Project Michael Veronin Follow this and additional works at: http://pubs.lib.umn.edu/innovations Recommended Citation Veronin M. Enhancing Personal Health Record Adoption Through the Community Pharmacy Network: A Service Project. Inov Pharm. 2015;6(4): Article 221. http://pubs.lib.umn.edu/innovations/vol6/iss4/3 INNOVATIONS in pharmacy is published by the University of Minnesota Libraries Publishing. Idea Paper INSIGHTS Enhancing Personal Health Record Adoption Through the Community Pharmacy Network: A Service Project Michael Veronin, PhD, RPh Department of Pharmaceutical Sciences, Ben and Maytee Fisch College of Pharmacy, The University of Texas at Tyler Key words: Personal Health Record, PHR, community pharmacy, ADDIE, health care quality No potential conflicts of interest or competing interests to disclose. No financial support or funding to disclose. Abstract Personal Health Records, or PHRs, are designed to be created, maintained and securely managed by patients themselves. PHRs can reduce medical errors and increase quality of care in the health care system through efficiency and improving accessibility of health information. Adoption of PHRs has been disappointingly low. In this paper a project is described—essentially a call for action—whereby the skills, expertise, and accessibility of the community pharmacist is utilized to address the problem of poor PHR adoption. The objective of this proposed project is to promote the expansion of PHR adoption directly at the consumer level by utilizing the existing infrastructure of community pharmacies.
    [Show full text]
  • Use of Electronic Health Record Data in Clinical Investigations Guidance for Industry1
    Use of Electronic Health Record Data in Clinical Investigations Guidance for Industry U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER) Center for Devices and Radiological Health (CDRH) July 2018 Procedural Use of Electronic Health Record Data in Clinical Investigations Guidance for Industry Additional copies are available from: Office of Communications, Division of Drug Information Center for Drug Evaluation and Research Food and Drug Administration 10001 New Hampshire Ave., Hillandale Bldg., 4th Floor Silver Spring, MD 20993-0002 Phone: 855-543-3784 or 301-796-3400; Fax: 301-431-6353 Email: [email protected] https://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/default.htm and/or Office of Communication, Outreach and Development Center for Biologics Evaluation and Research Food and Drug Administration 10903 New Hampshire Ave., Bldg. 71, Room 3128 Silver Spring, MD 20993-0002 Phone: 800-835-4709 or 240-402-8010 Email: [email protected] https://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/default.htm and/or Office of Communication and Education CDRH-Division of Industry and Consumer Education Center for Devices and Radiological Health Food and Drug Administration 10903 New Hampshire Ave., Bldg. 66, Room 4621 Silver Spring, MD 20993-0002 Phone: 800-638-2041 or 301-796-7100; Fax: 301-847-8149 Email: [email protected] https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/default.htm U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER) Center for Devices and Radiological Health (CDRH) July 2018 Procedural Contains Nonbinding Recommendations TABLE OF CONTENTS I.
    [Show full text]
  • Current Practices of Obesity Pharmacotherapy, Bariatric Surgery Referral and Coding for Counselling by Healthcare Professionals Christine Petrin, Scott Kahan, M
    Obesity Science & Practice doi: 10.1002/osp4.53 ORIGINAL ARTICLE Current practices of obesity pharmacotherapy, bariatric surgery referral and coding for counselling by healthcare professionals Christine Petrin, Scott Kahan, M. Turner, C. Gallagher and W. H. Dietz George Washington University, Summary Washington, DC, USA Introduction Received 21 April 2016; revised 7 June 2016; accepted 9 June 2016 Rates of obesity pharmacotherapy use, bariatric surgery and intensive behavioural counselling have been extremely low. Address for correspondence: C Petrin, Objectives George Washington University, 950 New Hampshire Ave NW Suite 300, Washington, DC 20037, USA. E-mail: cepetrin@gwmail. The primary objective of this study was to survey healthcare provider beliefs, practice gwu.edu and knowledge regarding obesity management. Methods Primary care physicians (PCPs), OB-GYN physicians and nurse practitioners (NPs) responded to a web-based survey related to drug therapy practice, bariatric surgery referral and reimbursement coding practice. Results Rates of reported use of obesity pharmacotherapy appear to be increasing among PCPs, which is likely related to the approval of four new obesity pharmacotherapy agents since 2012. Rates of pharmacotherapy use among OB-GYNs and NPs appear much lower. Similarly, few PCPs are averse to recommending bariatric surgery, but aversion among OB-GYNs and NPs is significantly higher. Conclusion Together, these observations suggest that OB-GYN and NP populations are important targets for education about obesity management. Very few PCPs, OB-GYNs or NPs use behavioural counselling coding for obesity. Better understanding of why this benefit is not being fully used could inform outreach to improve counselling rates. Keywords: Bariatric surgery referral, CPT coding, obesity counselling, obesity pharmacotherapy.
    [Show full text]
  • Exploring Indonesia's “Low Hospital Bed Utilization- Low Bed Occupancy-High Disease Burden” Paradox
    www.sciedu.ca/jha Journal of Hospital Administration, 2013, Vol. 2, No.1 ORIGINAL ARTICLE Exploring Indonesia’s “low hospital bed utilization- low bed occupancy-high disease burden” paradox Niyi Awofeso1, 2, Anu Rammohan3, Ainy Asmaripa4 1. School of Population Health, University of Western Australia, Cnr Gordon & Clifton Street Nedlands Campus, Australia. 2. School of Public Health, University of New South Wales, Sydney, Australia. 3. School of Business, Discipline of Economics, University of Western Australia, Crawley campus, Australia. 4. Faculty of Public health, Sriwijaya University, Indonesia Correspondence: Niyi Awofeso. Address: School of Population Health, University of Western Australia, M431, Cnr Gordon & Clifton Street Nedlands Campus, 6009, Australia. E-mail: [email protected] Received: October 8, 2012 Accepted: October 28, 2012 Online Published: November 22, 2012 DOI: 10.5430/jha.v2n1p49 URL: http://dx.doi.org/10.5430/jha.v2n1p49 Abstract Indonesia’s current hospital bed to population ratio of 6.3/10,000 compares unfavourably with a global average of 30/10,000. Despite low hospital bed-to-population ratio and a significant “double burden” of disease, bed occupancy rates range between 55% - 60% in both government and private hospitals in Indonesia, compared with over 80% hospital bed occupancy rates for the South-East Asian region. Annual inpatient admission in Indonesia is, at 140/10,000 population, the lowest in the South East Asian region. Despite currently low utilisation rates, Indonesia’s Human Resources for Health Development Plan 2011-2025 has among its objectives the expansion of hospital bed numbers to 10/10,000 population by 2014. The authors examined the reasons for the paradox and analysed the following contributory factors; health system’s shortcomings; epidemiological transition; medical tourism; high out-of-pocket payments; patronage of traditional medical practitioners, and increasing use of outpatient care.
    [Show full text]
  • Family Physicians As Team Leaders: “Time” to Share the Care
    VOLUME 6: NO. 2, A59 APRIL 2009 SPECIAL TOPIC Family Physicians as Team Leaders: “Time” to Share the Care Kimberly S. H. Yarnall, MD, Truls Østbye, MD, PhD, Katrina M. Krause, MA, Kathryn I. Pollak, PhD, Margaret Gradison, MD, J. Lloyd Michener, MD Suggested citation for this article: Yarnall KSH, Østbye T, Several interventions to improve preventive service Krause KM, Pollak KI, Gradison M, Michener JL. Family delivery and chronic disease management have been physicians as team leaders: “time” to share the care. tested. For example, Put Prevention Into Practice was an Prev Chronic Dis 2009;6(2):A59. http://www.cdc.gov/pcd/ effort to reorganize the delivery of preventive services, but issues/2009/apr/08_0023.htm. Accessed [date]. evaluations of this program failed to show significant sus- tained increases in preventive service delivery (4). Efforts PEER REVIEWED to automate reminder systems and improve efficiency in both prevention and chronic disease management have yielded initial improvements in randomized trials (5), but Abstract the effectiveness of computerized prompts appears to drop rapidly in the 6 months after implementation (6). A major contributor to shortfalls in delivery of recom- mended health care services is lack of physician time. On The common denominator in the failure to deliver ser- the basis of recommendations from national clinical care vices is probably lack of physician time. Our previous anal- guidelines for preventive services and chronic disease yses have suggested that primary care physicians simply management, and including the time needed for acute do not have enough time to deliver all the preventive and concerns, sufficiently addressing the needs of a standard chronic disease services recommended in national clinical patient panel of 2,500 would require 21.7 hours per day.
    [Show full text]
  • Pharmacotherapy Program Description 2020-2021
    PGY 1 & PGY 2 Pharmacotherapy Residency AMARILLO PROGRAM SUMMARY 2020-2021 !1 of 8! PGY 1 & PGY 2 PHARMACOTHERAPY - AMARILLO PURPOSE PGY1 Program PGY1 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and outcomes to contribute to the development of clinical pharmacists responsible for medication-related care of patients with a wide range of conditions, eligible for board certification, and eligible for postgraduate year two (PGY2) pharmacy residency training. PGY2 Program PGY2 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available. INTRODUCTION The PGY1/PGY2 Pharmacotherapy Residency is designed to produce a specialized practitioner with an advanced degree of proficiency and expertise in working with interdisciplinary teams to deliver comprehensive patient care to diverse populations from ambulatory care to critically ill, pediatric to geriatric ages, and presenting with varied and complex health problems.
    [Show full text]
  • ASHP Statement on Pharmaceutical Care
    Medication Therapy and Patient Care: Organization and Delivery of Services–Statements 331 ASHP Statement on Pharmaceutical Care The purpose of this statement is to assist pharmacists in under- Care. Central to the concept of care is caring, a personal standing pharmaceutical care. Such understanding must pre- concern for the well-being of another person. Overall cede efforts to implement pharmaceutical care, which ASHP patient care consists of integrated domains of care including believes merit the highest priority in all practice settings. (among others) medical care, nursing care, and pharmaceu- Possibly the earliest published use of the term pharma- tical care. Health professionals in each of these disciplines ceutical care was by Brodie in the context of thoughts about possess unique expertise and must cooperate in the patient’s drug use control and medication-related services.1,2 It is a overall care. At times, they share in the execution of the various term that has been widely used and a concept about which types of care (including pharmaceutical care). To pharma- much has been written and discussed in the pharmacy pro- ceutical care, however, the pharmacist contributes unique fession, especially since the publication of a paper by Hepler knowledge and skills to ensure optimal outcomes from the and Strand in 1990.3–5 ASHP has formally endorsed the con- use of medications. cept.6 With varying terminology and nuances, the concept At the heart of any type of patient care, there exists a has also been acknowledged by other national pharmacy or- one-to-one relationship between a caregiver and a patient.
    [Show full text]